Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-19-012009
Filing Date
2019-06-13
Accepted
2019-06-13 21:32:01
Documents
1
Period of Report
2019-06-11

Document Format Files

Seq Description Document Type Size
1 FORM 4 rdgdoc.html 4  
1 FORM 4 rdgdoc.xml 4 2769
  Complete submission text file 0001437749-19-012009.txt   4393
Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Issuer) CIK: 0001389545 (see all company filings)

EIN.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address FLAT 2605, 26/F TRENDY CENTRE 682 CASTLE PEAK ROAD KOWLOON K3 000000
Business Address FLAT 2605, 26/F TRENDY CENTRE 682 CASTLE PEAK ROAD KOWLOON K3 000000 86-21-50498982
Pioneer Pharma (Hong Kong) Co Ltd (Reporting) CIK: 0001593301 (see all company filings)

State of Incorp.: K3 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-33678 | Film No.: 19897472